Live Streaming Event
June 10th-11th 2021
On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
As marketing gets personalized and consumers expect to be reached on their channel of preference, pharma companies are spending significantly on marketing and sales. But, do all pharma companies have the technology? And are their marketing campaigns as successful as they should be?
This omnichannel marketing event aims to allow pharma companies to reach the right people, at the right time, and with the right message. While most pharma companies admit that they lack the resources to offer personalized consumer plans, they realize that personalization is the key to grab user attention. And with the changing landscape of the pharma arena owing to the COVID-19 impact, marketing strategies need to be revised and updated.
The event will present 17 World-Class speakers from the pharma and life science fraternity who will share their opinions and knowledge on omnichannel marketing. These eminent personalities will discuss the benefits of omnichannel marketing and explain to the attendees how integrating omnichannel processes will result in a stronger customer experience, increased brand awareness, improved insights, and high customer engagements and conversions.
Top reasons to attend:
This Omnichannel Marketing Strategy Symposium is the only life science event devoted to this industry that is being streamed live on a proven successful interactive platform. Omnichannel marketing offers a seamless consumer experience and is the future of life science marketing. The agenda of this online live streaming symposium is to educate life science professionals to plan and successfully implement strategies for better consumer engagement and conversions.
To know more about the event, please visit https://ibn.fm/7g3wP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate…
For a long time, scientists have been working tirelessly to come up with vaccines against cancer. Significant progress is…
A landmark Phase III trial published in The Lancet demonstrated a five-year overall survival rate…
Soligenix is entering a pivotal period marked by several anticipated clinical readouts and milestones expected…
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
Enormous resources are being channeled into studying different ways to support the immune system in its fight…